CD8A and neoplasm: To further establish causality, future studies could employ Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-mediated knockout or pharmacological inhibition of KMT2A/KDM6A in tumor-infiltrating CD8+T cells, followed by assessment of TRM phenotype and localization in vivo.